Potential Drug Interactions in Patients with Neurological Diseases at Hospital X in Pidie District, Aceh: quantitative descriptive study
Article metrics
OJS usage and citation sourcesViews and downloads are recorded by OJS; statistics processing may be delayed. A dash means the source count is unavailable. Search Google Scholar
Article Sidebar
Salmah Handayani Lubis, Fenny Hasanah, Desy Natalia Siahaan, Cut Intan (2026). Potential Drug Interactions in Patients with Neurological Diseases at Hospital X in Pidie District, Aceh: quantitative descriptive study. Journal of Pharmaceutical and Sciences, JPS Volume 9 Nomor 1 (2026). https://doi.org/10.36490/journal-jps.com.v9i1.1100
Main Article Content
Abstract
Background: Drug interactions can increase the risk of side effects and reduce the success of therapy, especially in neurological patients who often receive polypharmacy. Objective: This study aims to determine the effect of administering a combination of drugs as a trigger for potential drug interactions based on their classification (minor, moderate, major) in patients with neurological diseases. Methods: This study is a retrospective quantitative descriptive study with a cross-sectional design. The sample consisted of outpatient neurological patients who received more than two drugs that met the inclusion criteria. Potential drug interactions were analyzed using the https://www.drugs.com/drug_interactions.html. Results: The highest category of drug interactions was moderate (n= 52; 75%) with the following drug combinations: (amlodipine and bisoprolol); (Simvastatin + Miconazole); (Simvastatin + Omeprazole); (Hydrochlorothiazide + Codeine); (Codeine + Amitriptyline). In addition, a major drug interaction category (n=28; 25%) was found in the administration of drug combinations (simvastatin and amlodipine) causing liver damage; (Alprazolam + Codeine); (Diazepam + Codeine); (Codeine + Gabapentin) each of these three drug interactions can cause CNS depression, (Furosemide + Gentamicin) causes additive nephrotoxicity and ototoxicity. Conclusion: Moderate-category interactions were the most common (amlodipine and bisoprolol). These drug interactions included pharmacodynamic interactions, and the combination of these drugs could cause clinical risks (hypotension, bradycardia). These findings indicate the need for pharmacists to perform clinical pharmacy services related to prescription review and drug therapy monitoring for patients receiving more than two drugs, as well as providing information to patients on the appropriate timing and dosage of their medications to avoid moderate and major drug interactions in neurological patients in hospitals.
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
How to Cite
References
Harlyanti Muthma’innah Mashar MSD apt. MIY. MI dr. LEMMB apt. MAMMF apt. RHSF. MS apt. RTAMFK. Interaksi Obat Penerbit Cv.Eureka Media Aksara. 2023. 1–61 p.
Agustina R, Annisa N, Prabowo WC. Potensi Interaksi Obat Resep Pasien Hipertensi di Salah Satu Rumah Sakit Pemerintah di Kota Samarinda. J Sains dan Kesehat. 2015;1(4):208–13.
Ariani N, Prihandiwati E. Evaluasi Potensi Interaksi Obat Antidiabetika Oral Di Apotek Perintis Kuripan Banjarmasin. J Insa Farm Indones. 2021;4(2).
Sundari E, Maulita Y, Khair H. Penerapan Metode Bayes untuk Mendiagnosa Penyakit Saraf Kejepit Sistem Pakar dan andal yang menggunakan fakta dan heuristik untuk memecahkan masalah pengambilan yaitu suatu aplikasi computer yang ditujukan untuk membantu pengambilan keputusan atau. 2024;2(3).
Pricilia S, Kurniawan SN. Central vertigo. 2021;(2):38–43.
Setiawan D, Hadi S, Sari OM, Mardiati N, Budi MSS, Ramadhan F, et al. Promosi Kesehatan Tentang Obat Amlodipin Dan Simvastatin Serta Cara Penggunaannya. EJOIN J Pengabdi Masy. 2023;1(12):1382–7.
Kania M, Adiana S. Jalan Eksekutif Poliklinik Penyakit Dalam Di Rumah Sakit X Periode Januari-Maret 2023. 2024;4(4):292–7.
Constantia N, Aulia H, Subarnas A. REVIEW ARTICLE Analysis of potential interactions between drugs in polypharmacy prescriptions in Bandung City pharmacies Analisis potensi interaksi antar obat pada resep polifarmasi di apotek kota Bandung Abstrak Pendahuluan. 2024;(September 2023):94–9.
Agustin OA, Fitrianingsih F. Kajian Interaksi Obat Berdasarkan Kategori Signifikansi Klinis Terhadap Pola Peresepan Pasien Rawat Jalan Di Apotek X Jambi. Electron J Sci Environ Heal Dis. 2021;1(1):1–10.
Sari L. Pola Peresepan Penyakit Stroke Iskemik Pasien Rawat Jalan Rumah Sakit di Kota Sungailiat. J Kesehat Poltekkes Kemenkes Ri Pangkalpinang. 2020;7(2):42.
Oktianti D, Septina Widyadewi PP, Wati DR. Identfikasi Potensi Interaksi Obat Antihipertensi Pada Pasien Rawat Jalan Di Rs X Denpasar Periode Oktober-Desember 2021. INPHARNMED J (Indonesian Pharm Nat Med Journal). 2023;6(2):82.
Heltiani N, Asroni N, Suryani TE, Stikes ), Bakti S. Analisis Ketepatan Kode Diagnosa Obstetri Terhadap Kelancaran Klaim Bpjs Rs.X Kota Bengkulu Analysis of the Accuracy of the Obstetrical Diagnosis Code of the Smoothness of Claims Bpjs Rs.X Bengkulu City. J Inf Kesehat Indones. 2023;9(1):1–11.
Septipalan ML, Hibrizi MS, Latifah N, Lina R, Bimantoro F. Klasifikasi Tumor Otak Menggunakan CNN Dengan Arsitektur Resnet50. Semin Nas Teknol Sains. 2024;3(1):103–8.
Pradipta IS, Pratama D, Khatami H, Sanggelorang J. Potential Drug-Drug Interaction in the Intensive Care Unit: An Observational Study at a Hospital in Bandung. Indones J Clin Pharm. 2022;11(1):41–50.
Kusuma IY. Pharmacoscript Volume 3 No.1 Februari 2020. 2020;3(1):1–12.
Suriyapakorn B, Chairat P, Boonyoprakarn S, Lucksiri A, Pongwecharak J. Comparison of potential drug–drug interactions with metabolic syndrome medications detected by two databases. PLoS One. 2019;14(11):e0225239. doi:10.1371/journal.pone.0225239
Aqil M, Khan MI, Alam MS, Pillai KK, Kapur P. Assessment of drug–drug interactions in the outpatient department of a tertiary care hospital in New Delhi, India. Gavin J Med Clin Res. 2019;2(2):1–7. Available from:https://www.gavinpublishers.com/article/view/assessment-of-drug-drug-interactions-in-the-outpatient-department-of-a-tertiary-care-hospital-in-new-delhi-india
Mekonnen AB, Redley B, de Courten B, Manias E. Detection and categorization of clinically significant drug–drug interactions among hospitalized patients: a comparison between three databases. BMC Pharmacol Toxicol. 2022;23(1):61. doi:10.1186/s40360-022-00572-9.
Lexicomp Online Database [Internet]. Hudson (OH): Wolters Kluwer Health, Inc. c2024 [cited 2025 Oct 17]. Available from: https://www.wolterskluwer.com/en/solutions/lexicomp
Drugs.com. Drug Interactions Checker [Internet]. c2000–2025 [cited 2025 Oct 17]. Available from: https://www.drugs.com/drug_interactions.html
De Oliveira, L.M., Diel, J.D.A.C., Nunes, A., Da Silva Dal Pizzol, T., 2021. Prevalence Of Drug Interactions in Hospitalised Elderly Patients: A Systematic Review. European Journal of Hospital Pharmacy. https://doi.org/10.1136/ejhpharm-2019-002111
Benjamin L. P. Lee. (2016). Basic Principles of Drug Discovery and Development. Edisi: 1st Edition. https://www.amazon.com/Basic-Principles-Drug Discovery-Development/dp/0128017854.
Bertram G. Katzung (2021). Basic and Clinical Pharmacology. Edisi: 14th Edition, https://www.amazon.com/Basic-Clinical Pharmacology-Bertram-Katzung/dp/1260246537.
Setiadi F. dkk (2024). “Potensi Interaksi Obat Pada Pasien Penyakit Jantung Koroner Akut Di Rawat Inap Rumah Sakit Fatmawati Tahun 2023.” Jurnal Farmasi Klinis Best Practice, Jakarta, p. 1. Online:https://rsupfatmawati.co.id/jfklin/index.php /jfklin/article/view/54
Flori Ratna, Saiful Anwar dan Nur Layli (2024). Potensi Interaksi Obat Di Rumah Sakit dan Pemanfaatan Drug Alert System. https://deepublishstore.com/ebook/e-book 140 potensi-interaksi-obat-di-rumah-sakit-dan pemanfaatan/?utm_source=chatgpt.com#sinopsis ebook.
H.P. Rang, M.M. Dale, J.M. Ritter, R.J. Flower. (2016). Pharmacology. Edisi: 8th Edition. https://www.amazon.com/Pharmacology-H-P Rang/dp/0702052549.